[go: up one dir, main page]

TNSN99213A1 - Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation - Google Patents

Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation

Info

Publication number
TNSN99213A1
TNSN99213A1 TNTNSN99213A TNSN99213A TNSN99213A1 TN SN99213 A1 TNSN99213 A1 TN SN99213A1 TN TNSN99213 A TNTNSN99213 A TN TNSN99213A TN SN99213 A TNSN99213 A TN SN99213A TN SN99213 A1 TNSN99213 A1 TN SN99213A1
Authority
TN
Tunisia
Prior art keywords
milbemycin
preparation
pest control
formulations containing
control formulations
Prior art date
Application number
TNTNSN99213A
Other languages
English (en)
Inventor
Michael Lukas Timothy
Richard Wicks Stephen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN99213(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN99213A1 publication Critical patent/TNSN99213A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'INVENTION CONCERNE UNE FORMULATION ANTIPARASITAIRE POUR APPLICATION TOPIQUE, COMPRENANT UNE AVERMECTINE OU MILBEMYCINE, UN ETHER DE MONO (ALKYLE EN C1 A C4) DE DI(GLYCOL EN C2 A C4), UN ANTIOXYDANT FACULTATIF ET UN SOLVANT VOLATIL FACULTATIF. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE FORMULATION POUR LE TRAITEMENT D'UNE AFFECTION PROVOQUEE PAR UN ENDO- OU ECTO-PARASITE.
TNTNSN99213A 1998-11-19 1999-11-17 Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation TNSN99213A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825402.2A GB9825402D0 (en) 1998-11-19 1998-11-19 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
TNSN99213A1 true TNSN99213A1 (fr) 2005-11-10

Family

ID=10842728

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99213A TNSN99213A1 (fr) 1998-11-19 1999-11-17 Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation

Country Status (43)

Country Link
US (1) US6797701B2 (fr)
EP (2) EP1522219B1 (fr)
JP (1) JP3507799B2 (fr)
KR (1) KR100458406B1 (fr)
CN (1) CN1147232C (fr)
AP (1) AP1210A (fr)
AR (1) AR023062A1 (fr)
AT (2) ATE288201T1 (fr)
BG (1) BG65440B1 (fr)
BR (1) BR9915458B1 (fr)
CA (1) CA2351730C (fr)
CO (1) CO5150175A1 (fr)
CY (1) CY1111955T1 (fr)
CZ (1) CZ304345B6 (fr)
DE (2) DE69942465D1 (fr)
DK (2) DK1522219T3 (fr)
DZ (1) DZ2945A1 (fr)
EA (1) EA003959B1 (fr)
ES (2) ES2344505T3 (fr)
GB (1) GB9825402D0 (fr)
GT (1) GT199900197A (fr)
HK (1) HK1040593B (fr)
HR (1) HRP20010368B1 (fr)
HU (1) HU229493B1 (fr)
ID (1) ID28698A (fr)
IL (3) IL142104A0 (fr)
IS (1) IS5907A (fr)
MA (1) MA25029A1 (fr)
NO (1) NO20012389D0 (fr)
NZ (2) NZ537110A (fr)
OA (1) OA11678A (fr)
PA (1) PA8485501A1 (fr)
PE (1) PE20001319A1 (fr)
PL (1) PL204763B1 (fr)
PT (2) PT1522219E (fr)
SI (2) SI1130966T2 (fr)
SK (1) SK287540B6 (fr)
TN (1) TNSN99213A1 (fr)
TW (1) TW526045B (fr)
UY (1) UY25806A1 (fr)
WO (1) WO2000030449A1 (fr)
YU (1) YU23401A (fr)
ZA (1) ZA997174B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
WO2001020994A1 (fr) * 1999-09-22 2001-03-29 Ashmont Holdings Limited Traitement cutane par deversement pour mouton
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
SK1282004A3 (en) 2001-09-17 2004-08-03 Lilly Co Eli Pesticidal formulations
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
GB2444572B (en) * 2006-12-05 2011-10-19 Michael Hilary Burke A process for the preparation of a stable anhydrous anthelmintic formulation
AU2010233409B2 (en) * 2009-02-16 2012-05-17 Zoetis Services Llc High dosage doramectin formulation
EP2416663A2 (fr) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Formulation parasiticide
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) * 2010-06-17 2012-03-13 Rotam Agrochem International Company Ltd Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
KR20130044330A (ko) * 2010-07-30 2013-05-02 세바 상뜨 아니말르 사상충 체내 감염증을 조절하기 위한 조성물
WO2012054331A1 (fr) * 2010-10-20 2012-04-26 Galderma S.A. Méthode de traitement de l'otite externe à l'aide d'un composé de lactone macrocyclique
IT1403631B1 (it) * 2011-01-14 2013-10-31 Gsi Geosyntec Invest B V Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) * 2011-03-18 2011-07-29 "Ендектовет" Еоод Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) * 2011-08-25 2013-08-13 Eurofarma Lab Ltda composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
EP2768513B8 (fr) * 2011-10-18 2020-05-20 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Utilisation d'un dérivé d'avermectine pour augmenter la biodisponibilité et l'efficacité des lactones macrocycliques
PL2785719T3 (pl) 2011-12-02 2018-03-30 Merial, Inc. Długodziałające wstrzykiwalne postaci moksydektyny i nowe postaci krystaliczne moksydektyny
CN109673653A (zh) * 2012-04-04 2019-04-26 先正达参股股份有限公司 杀有害生物剂组合物
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
HK1219623A1 (zh) * 2013-05-20 2017-04-13 Zoetis Services Llc 長效的螺環-異惡唑啉抗寄生蟲組合物
WO2016022066A1 (fr) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Compositions pharmaceutiques pour blépharite et encroûtement des paupières liés à demodex
EP3595441B1 (fr) 2017-03-17 2023-08-02 KRKA, d.d., Novo mesto Composition veterinaire topique stable
KR20200090165A (ko) * 2017-11-23 2020-07-28 세바 상뜨 아니말르 기생충 감염 치료용 목시텍틴 함유 조성물
KR20250065422A (ko) 2017-12-15 2025-05-12 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
JPS4914624A (fr) * 1972-06-08 1974-02-08
US3839234A (en) 1973-01-26 1974-10-01 C Roscoe Multi-purpose cleaning concentrate
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
EP0170006B1 (fr) * 1984-06-05 1992-07-08 American Cyanamid Company Agents et leurs méthodes de production, méthodes et compositions contenant ces agents pour lutter contre les infections dûes aux helminthes, aux arthropodes, aux ectoparasites et aux acariens
EP0192009B1 (fr) 1985-01-22 1991-09-04 Saint-Gobain Vitrage International Procédé de prèparation d'un poudre à base de formiate d'indium pour la formation d'une couche mince sur un substrat, notamment en verre.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de) 1985-12-20 1987-07-02 Autotyp Sa Schneekette fuer fahrzeugraeder
LU86393A1 (fr) 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
EP0254583B1 (fr) * 1986-07-24 1994-09-07 Beecham Group Plc Dérivés de la milbémycine à activité parasiticide, un procédé pour leur préparation et les compositions les contenant
BG48572A3 (bg) * 1987-01-23 1991-03-15 Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware Метод за получаване на авермектини
DE3727648A1 (de) † 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8807280D0 (en) * 1988-03-26 1988-04-27 Pfizer Ltd Antiparasitic agents
FR2630576B1 (fr) * 1988-04-26 1990-08-17 Realisations Nucleaires Et Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
US4973468A (en) † 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
JP2978245B2 (ja) † 1990-03-05 1999-11-15 マリンクロット ベタリナリイ，インコーポレイテッド 寄生虫防除組成物ならびにその製造法および使用法
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5411737A (en) † 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
JP3966479B2 (ja) * 1993-04-16 2007-08-29 日本テキサス・インスツルメンツ株式会社 ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
ATE245900T1 (de) * 1993-05-10 2003-08-15 Merck & Co Inc Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
TW327125B (en) * 1994-02-07 1998-02-21 Merck & Co Inc Composition and method for protecting against pine exhausted
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
DE19520275A1 (de) † 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE69716880T2 (de) 1996-01-30 2003-07-17 Takeda Chemical Industries, Ltd. 1-arylpyrazole insektizide
DE19612644A1 (de) † 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
FI107528B (fi) 1998-12-23 2001-08-31 Kemira Chemicals Oy Menetelmä muurahaishapon valmistamiseksi

Also Published As

Publication number Publication date
AU5995999A (en) 2000-06-13
CY1111955T1 (el) 2015-11-04
SK6622001A3 (en) 2001-12-03
NZ537110A (en) 2006-04-28
ATE288201T1 (de) 2005-02-15
HRP20010368B1 (en) 2004-06-30
DE69923583D1 (de) 2005-03-10
IS5907A (is) 2001-03-23
PL348638A1 (en) 2002-06-03
US6797701B2 (en) 2004-09-28
CN1147232C (zh) 2004-04-28
KR100458406B1 (ko) 2004-11-26
CA2351730C (fr) 2006-12-05
US20020028780A1 (en) 2002-03-07
EP1130966A1 (fr) 2001-09-12
HRP20010368A2 (en) 2002-06-30
BG105601A (en) 2002-01-31
ZA997174B (en) 2001-05-18
ID28698A (id) 2001-06-28
BR9915458A (pt) 2001-07-17
CO5150175A1 (es) 2002-04-29
DE69923583T2 (de) 2006-01-12
AP9901697A0 (en) 1999-12-31
PT1522219E (pt) 2010-07-19
EP1522219A1 (fr) 2005-04-13
EP1130966B2 (fr) 2009-05-27
PT1130966E (pt) 2005-04-29
DK1522219T3 (da) 2010-08-16
NO20012389L (no) 2001-05-15
PL204763B1 (pl) 2010-02-26
SK287540B6 (sk) 2011-01-04
HUP0104235A2 (hu) 2002-03-28
JP2002530302A (ja) 2002-09-17
CZ304345B6 (cs) 2014-03-19
JP3507799B2 (ja) 2004-03-15
ES2237213T3 (es) 2009-08-19
HUP0104235A3 (en) 2004-03-01
CN1326318A (zh) 2001-12-12
OA11678A (en) 2005-01-12
DE69942465D1 (de) 2010-07-15
BR9915458B1 (pt) 2011-04-19
HK1040593B (zh) 2004-10-08
SI1522219T1 (sl) 2010-09-30
HU229493B1 (en) 2014-01-28
NO20012389D0 (no) 2001-05-15
EA003959B1 (ru) 2003-10-30
SI1130966T1 (en) 2005-06-30
DK1130966T3 (da) 2005-05-09
ES2344505T3 (es) 2010-08-30
IL173567A0 (en) 2006-07-05
EP1130966B1 (fr) 2005-02-02
WO2000030449A1 (fr) 2000-06-02
AR023062A1 (es) 2002-09-04
EP1522219B1 (fr) 2010-06-02
GB9825402D0 (en) 1999-01-13
CZ20011734A3 (cs) 2001-12-12
GT199900197A (es) 2001-05-10
HK1040593A1 (en) 2002-06-21
SI1130966T2 (sl) 2009-08-31
TW526045B (en) 2003-04-01
MA25029A1 (fr) 2000-07-01
PA8485501A1 (es) 2000-09-29
NZ510678A (en) 2003-08-29
CA2351730A1 (fr) 2000-06-02
DK1130966T4 (da) 2009-07-20
IL142104A (en) 2006-06-11
AU757892B2 (en) 2003-03-13
YU23401A (sh) 2005-06-10
AP1210A (en) 2003-09-30
PE20001319A1 (es) 2000-12-02
KR20010080505A (ko) 2001-08-22
UY25806A1 (es) 2001-08-27
BG65440B1 (bg) 2008-08-29
EA200100458A1 (ru) 2001-10-22
ATE469550T1 (de) 2010-06-15
DE69923583T3 (de) 2009-12-24
DZ2945A1 (fr) 2004-03-15
IL142104A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
TNSN99213A1 (fr) Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation
DE69625374D1 (en) (methylsulfonyl)phenyl-2-(5h)-furanone als cox-2 inhibitoren
BR9401183A (pt) Composto e formulação farmacêutica
ES2145933T3 (es) Formulacion para la conservacion de la madera que comprende un complejo de un cation cobre y una diamina alcoxilada.
FR2419758A1 (fr) Composition de gel
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
ES2060031T3 (es) Formulacion que contiene un derivado de imidazo(4,5-c)quinoleina.
ATE26705T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung, und pharmazeutische praeparate, die diese verbindungen enthalten.
DE69618820D1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
FR2387229A1 (fr) Dipyrido (4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
IL58782A0 (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
AU580822B2 (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
AU623805B2 (en) New use of anti-progestomimetic compounds
FR2363563A1 (fr) Nouveaux derives de 1-acyloxymethyl-5-fluorouracile utiles notamment comme agents antitumoraux, et leur procede de preparation
TNSN99225A1 (fr) Formulations de doramectine antiparasitaires et procede pour leur preparation
KR900003174A (ko) 벤조푸로[3,2-c] 퀴놀린 화합물
FR2424894A1 (fr) Tricycloaldehydes a, b-insatures, leur procede de preparation et leur application en tant qu'agents parfumants
TNSN97191A1 (fr) Dimesylate de cis-1-(3 ethoxyphenyl)-1-(4-phenyl-piperazine-1- yl)-4- methylcyclohexane, procede pour sa preparation et composition pharmaceutique.
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
ES511302A0 (es) "metodo para la preparacion de composiciones farmaceuticas conteniendo sulfadiazina de plata como sustancia activa".
FR2419286A2 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
JPS57142980A (en) 7beta,11,12-trihydroxy-6,20-epoxymethano-abieta-8,11,13-triene- 20-one and antioxidant therefrom